Northern Trust Corp Pro Phase Labs, Inc. Transaction History

Northern Trust Corp

$761 Billion
Q3 2025

A detailed history of Northern Trust Corp transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 23,214 shares of PRPH stock, worth $6,964. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,214

Previous 23,214 -0.0%

Holding current value

$6,964

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.24 - $0.88 $3,242 - $11,889	-13,511 Reduced 36.79%	23,214 $9,000
Q4 2024 Feb 14, 2025	SELL	$0.61 - $2.47 $2,915 - $11,804	-4,779 Reduced 11.51%	36,725 $27,000
Q3 2024 Nov 13, 2024	SELL	$2.16 - $4.06 $643 - $1,209	-298 Reduced 0.71%	41,504 $100,000
Q2 2024 Aug 14, 2024	SELL	$4.18 - $7.35 $4,986 - $8,768	-1,193 Reduced 2.77%	41,802 $174,000
Q1 2024 May 14, 2024	SELL	$4.47 - $6.47 $13,262 - $19,196	-2,967 Reduced 6.46%	42,995 $278,000

Q4 2023 Feb 13, 2024	BUY	$4.35 - $5.1 $98,040 - $114,943	22,538 Added 96.22%	45,962 $207,000
Q3 2023 Nov 13, 2023	SELL	$4.23 - $7.53 $807 - $1,438	-191 Reduced 0.81%	23,424 $102,000
Q2 2023 Aug 11, 2023	SELL	$7.15 - $9.78 $500 - $684	-70 Reduced 0.3%	23,615 $171,000
Q1 2023 May 15, 2023	BUY	$6.62 - $9.57 $10,433 - $15,082	1,576 Added 7.13%	23,685 $180,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $32,820 - $53,846	3,663 Added 19.86%	22,109 $249,000
Q2 2022 Aug 12, 2022	SELL	$6.52 - $13.24 $2,738 - $5,560	-420 Reduced 2.23%	18,446 $234,000
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.82 $4,811 - $7,694	-984 Reduced 4.96%	18,866 $98,000
Q2 2021 Aug 13, 2021	SELL	$4.61 - $6.83 $68,868 - $102,033	-14,939 Reduced 42.94%	19,850 $123,000
Q1 2021 May 12, 2021	SELL	$6.19 - $16.0 $72,342 - $186,992	-11,687 Reduced 25.15%	34,789 $257,000
Q4 2020 Feb 11, 2021	BUY	$3.9 - $11.25 $22,893 - $66,037	5,870 Added 14.46%	46,476 $426,000
Q3 2020 Nov 16, 2020	SELL	$1.4 - $3.87 $828 - $2,291	-592 Reduced 1.44%	40,606 $141,000
Q4 2019 Feb 14, 2020	SELL	$1.66 - $2.2 $13 - $17	-8 Reduced 0.02%	41,198 $81,000
Q1 2019 May 13, 2019	BUY	$2.7 - $3.65 $1,144 - $1,547	424 Added 1.04%	41,206 $124,000
Q4 2018 Feb 12, 2019	SELL	$2.95 - $3.27 $1,649 - $1,827	-559 Reduced 1.35%	40,782 $128,000
Q2 2018 Aug 14, 2018	SELL	$2.84 - $5.41 $9,389 - $17,885	-3,306 Reduced 7.4%	41,341 $134,000
Q1 2018 May 09, 2018	BUY	$2.24 - $3.21 $66,102 - $94,727	29,510 Added 194.95%	44,647 $132,000
Q4 2017 Feb 14, 2018	SELL	$2.05 - $2.3 $1,432 - $1,607	-699 Reduced 4.41%	15,137 $33,000
Q3 2017 Nov 13, 2017	BUY	$2.03 - $2.29 $32,147 - $36,264	15,836	15,836 $34,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

2.98M

Call Options Held

13.7K

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $4.81M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Pro Phase Labs, Inc. Transaction History